Posters
Glomerular Diseases: Membranous Nephropathy, FSGS, and Podocytopathies
October 23, 2026 | 10:00 AM - 12:00 PM
Location: Exhibit Hall A, Convention Center
Session Description
Poster Session
Posters
Minimal Change Disease Associated with a Neuroendocrine Tumor of Unknown Primary
Collapsing Glomerulopathy with an Unusual Twist
Tenofovir-Induced Tubulopathy and Podocytopathy in a Patient with Chronic Hepatitis B: A Double-Hit Hypothesis
A Case Report of NELL-1-Positive Membranous Nephropathy Associated with Thymoma
A Paradoxical Case of Phospholipase A2 Receptor Antibody Seropositivity with NELL-1 Membranous Nephropathy
Collapsing FSGS Progression to ESRD After Combination Therapy with Pembrolizumab and Enfortumab Vedotin: A Case Report
Seroconversion in Membranous Nephropathy: From Seronegative to Seropositive Disease
Neurorenal Autoimmunity Unveiled: Atypical Guillain-Barre Syndrome with Concurrent NELL-1-Positive Membranous Nephropathy
Differing Phospholipase A2 Receptor (PLA2R) Antibody Decline Kinetics After Obinutuzumab in High-Risk Membranous Nephropathy: Report of Two Cases
Mixed Membranous Nephropathy Presenting as Severe Autoimmune Hemolytic Anemia
NELL-1 Membranous Nephropathy Associated with Alpha-Lipoic Acid Infusions
When Autoantibodies Mislead: Biopsy-Proven Collapsing HIV-Associated Nephropathy Mimicking Autoimmune Glomerulonephritis
From Flank Pain to Graft-vs.-Host Disease-Related Autoimmune Podocytopathy: A Case of FAT1+ Membranous Nephropathy
From Alopecia to Antigen: Mass Spectrometry Reveals Neuron-Derived Neurotrophic Factor-Positive Membranous Nephropathy
The Great Imitator: Syphilis-Induced Membranous Nephropathy
When Phospholipase A2 Receptor Meets Hepatitis B: Navigating Primary vs. Secondary Membranous Nephropathy
NELL-1-Positive Membranous Nephropathy Secondary to Borrelia burgdorferi Infection
Fabry Disease Presenting with Collapsing Glomerulopathy and Advanced CKD: Diagnostic Confirmation by Electron Microscopy in the Absence of Genetic Testing
Obinutuzumab for Rituximab-Refractory Membranous Nephropathy Secondary to Sjögren Syndrome
Exostosin 1/2-Positive Membranous Nephropathy Associated with Methicillin-Sensitive Staphylococcus aureus Lung Abscess: Where Are the Autoantibodies?
Pseudo-Fabry Nephropathy: When Myeloid Bodies Mislead
Refractory Seropositive but Biopsy-Negative Anti-Nephrin Antibody-Associated Podocytopathy: A Case Report
A Rare Case of Primary Membranous Nephropathy in Pregnancy
NELL-1-Associated Membranous Nephropathy Secondary to a Suspected Connective Tissue Disorder with Concurrent Immune-Mediated Thrombotic Thrombocytopenic Purpura
Primary Podocytopathy Phenotype with APOL1 High-Risk Genotype Presenting as Severe Nephrotic Syndrome During Pregnancy
Atypical Presentation of EXT1/EXT2 Membranous Nephropathy
Unsolved Mysteries: A Case of Isolated Podocyte Infolding Glomerulopathy
A Double-Edged Sword: Gene Therapy as a Potential Second-Hit for APOL1-Mediated Kidney Disease
When Rituximab Isn't Enough: A Case of Rituximab-Resistant Minimal Change Disease
Partial Remission of Phospholipase A2 Receptor (PLA2R) Antibody-Positive Membranous Nephropathy Refractory to Rituximab with Use of Obinutuzumab
Crescents and a "Full House" in Sjögren Syndrome: EXT1-Positive Secondary Membranous Nephropathy
Budoprutug for Minimal Change Disease (MCD): A Case Study of Durable Response and Potential Disease Modification via CD19+ B-Cell Depletion
A Case of a Pediatric Patient with Minor Glomerular Abnormality and Mild Renal Function Decline Caused by a Novel MAFB Variant
When Antibodies Persist: A Case of Graft-vs.-Host Disease-Associated NELL-1 Membranous Nephropathy
Membranous-Like Glomerulopathy with Masked IgG Kappa Deposits in a 70-Year-Old Woman: Expanding the Age Spectrum of a Rare Entity
When Nephrotic Syndrome Turns Chylous: Phospholipase A2 Receptor Antibody-Positive Membranous Nephropathy with Renal Vein Thrombosis
Precision Nephrology: Antigen-Guided Conservative Management in Two Patients with Membranous Nephropathy
Remission of Minimal Change Disease During Acute Measles Infection
Beyond Anabolic Steroids: FSGS Associated with Testosterone Replacement Therapy
Enteric Infection-Associated Chronic Active Interstitial Nephritis and Collapsing Glomerulopathy in a Patient with a COL4A3 Variant
T-Cell Large Granular Lymphocytic Leukemia (T-LGL) as a Potential Trigger for Collapsing Glomerulopathy in a Patient with an APOL1 High-Risk Genotype
NELL-1-Positive Membranous Nephropathy in a Patient with Hematologic Malignancy Without Graft-vs.-Host Disease
From Headache to Hemodialysis: Undiagnosed HIV Presenting as APOL1-Associated Collapsing Glomerulopathy
When Inflammation Meets Genetics: A Suspected Second-Hit Trigger of APOL1-Carrier-Associated FSGS
Collapsing FSGS as a Complication of Sjogren Syndrome: The Importance of Testing for Proteinuria
Obinutuzumab Alone to Successfully and Rapidly Treat Refractory Minimal Change Disease in a Patient with ADPKD
Minimal Change Disease in a Patient with Type 1 Neurofibromatosis and User of Smokeless Tobacco and Cannabis: A Case Report
"Store It Away": Renal Dysfunction in Glycogen Storage Disease Type Ia
Problems with Podocytes and Platelets: Minimal Change Disease (MCD) and Acquired Amegakaryocytic Thrombocytopenia (AAMT)
Lenvatinib-Associated FSGS Beyond Thrombotic Microangiopathy
Dusting of Podocytes in Late-Onset Minimal Change Disease: An Unusual Histologic Pattern Suggesting Antinephrin-Mediated Podocytopathy on Kidney Biopsy
When Fifth Disease Becomes a Sixth Hit: Parvovirus B19-Associated Collapsing FSGS
Biopsy-Proven Minimal Change Disease in a Patient with Primary Biliary Cholangitis
Membranous Nephropathy Associated with Compounded Tirzepatide: Cause, Cure, or Coincidence
Rapid Progression to ESKD in a Patient with Tissue-Positive, Seronegative Phospholipase A2 Receptor Membranous Nephropathy
Tirzepatide-Associated Minimal Change Disease: A Case Report
NELL-1 Membranous Nephropathy Without Malignancy or Known Exposure: A Diagnostic Challenge in Seronegative Nephrotic Disease
An Unusual Presentation of Membranous Nephropathy with Primary and Secondary Features
From Proteinuria to Precision Nephrology: Suspected APOL1-Associated FSGS Treated with Early Sparsentan and SGLT2 Inhibition